Starpharma Changes Chair After 12 Years as Vested Rights Add Shares
Starpharma appointed Dr Russell Basser chair after the AGM, ending Rob Thomas’s 12-year tenure in the role; Thomas remains a non-executive director, and David McIntyre became deputy chair. Separately, about 3.2 million shares were issued on 30 October after employee performance rights vested, bringing the expected total to about 483 million shares following quotation.

Comments